HCA Healthcare, Inc. $HCA Shares Sold by Hsbc Holdings PLC

Key Points

• Hsbc Holdings PLC has lowered its stake in HCA Healthcare by 9.8%, selling 37,594 shares, and now owns 346,935 shares valued at approximately $119.68 million.
• HCA Healthcare reported $6.84 EPS for the latest quarter, beating estimates, and had revenue of $18.61 billion, reflecting a 6.4% increase year-over-year.
• The company announced a quarterly dividend of $0.72 per share, resulting in an annualized yield of 0.7% and a payout ratio of 12.11%.

Hsbc Holdings PLC decreased its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 9.8% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 346,935 shares of the company's stock after selling 37,594 shares during the quarter. Hsbc Holdings PLC owned 0.14% of HCA Healthcare worth $119,681,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Brown Advisory Inc. boosted its stake in shares of HCA Healthcare by 53.9% during the 1st quarter. Brown Advisory Inc. now owns 4,630 shares of the company's stock worth $1,600,000 after acquiring an additional 1,622 shares in the last quarter. Farther Finance Advisors LLC boosted its stake in shares of HCA Healthcare by 26.9% during the 1st quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company's stock worth $395,000 after acquiring an additional 242 shares in the last quarter. Oppenheimer Asset Management Inc. boosted its stake in shares of HCA Healthcare by 2.5% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 4,314 shares of the company's stock worth $1,491,000 after acquiring an additional 105 shares in the last quarter. GAMMA Investing LLC lifted its stake in HCA Healthcare by 17.6% in the 1st quarter. GAMMA Investing LLC now owns 4,931 shares of the company's stock valued at $1,704,000 after buying an additional 737 shares in the last quarter. Finally, J.W. Cole Advisors Inc. lifted its stake in HCA Healthcare by 145.3% in the 1st quarter. J.W. Cole Advisors Inc. now owns 3,550 shares of the company's stock valued at $1,227,000 after buying an additional 2,103 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

Wall Street Analysts Forecast Growth

HCA has been the topic of a number of recent research reports. Bank of America lowered HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 target price on the stock. in a research note on Wednesday, July 16th. Robert W. Baird upped their target price on HCA Healthcare from $380.00 to $423.00 and gave the company a "neutral" rating in a research note on Thursday, August 14th. Truist Financial increased their price target on HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a research note on Wednesday, July 16th. Wolfe Research lowered HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday, July 28th. Finally, Morgan Stanley reduced their price target on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a research note on Monday, July 28th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $398.58.

HCA Healthcare Trading Up 0.2%

Shares of HCA stock traded up $0.61 on Friday, reaching $404.87. 1,081,188 shares of the stock were exchanged, compared to its average volume of 1,431,386. The stock has a market cap of $94.74 billion, a P/E ratio of 17.02, a price-to-earnings-growth ratio of 1.27 and a beta of 1.39. The company has a quick ratio of 0.86, a current ratio of 0.98 and a debt-to-equity ratio of 69.07. The firm has a 50 day moving average of $373.91 and a two-hundred day moving average of $354.02. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. The business had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The business's revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the prior year, the firm posted $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be issued a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare's dividend payout ratio is currently 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.